As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients’ Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
The independent source for health policy research, polling, and news.
1,461 - 1,480 of 1,850 Results
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book “The Price We Pay” about why health care costs so much.
One groom’s bachelor party hangover illustrates how emergency room bills have become major headaches for many Americans.
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
State regulators and even one medevac company have raised doubts about prepaid subscriptions and promised benefits offered by air ambulance companies.
But critics say the new policy still leaves some patients exposed to lawsuits and crippling bills.
It turns out the health care plans put forth by the campaigns of former Vice President Joe Biden and former Cabinet secretary Julián Castro are not that different.
Sen Bernie Sanders' statement during Thursday night's Democratic debate serves up interesting data, with a side of misrepresentation.
KHN reported this week that the University of Virginia Health System has filed 36,000 lawsuits against patients the past six years.
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.
A Kaiser Health News investigation, which first appeared in The Washington Post, showed that the University of Virginia Health System has sued patients 36,000 times for more than $106 million.
Over six years, the state institution filed 36,000 lawsuits against patients seeking a total of more than $106 million in unpaid bills, a KHN analysis finds.
A long-awaited class-action lawsuit against Sutter is set to open this month in San Francisco Superior Court. The hospital giant stands accused of violating California’s antitrust laws by leveraging its market power to drive out competition and overcharge patients.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Groupon and other deal sites are the latest marketing tactic in medicine, offering bargain prices but potentially unnecessary, duplicative services.
When Kansas elected Laura Kelly as governor, Medicaid expansion looked like a shoo-in, with seemingly broad support across state government. It didn’t happen. A look at conservatives’ new health care playbook and the politics of obstruction. Health care for 130,000 Kansans hangs in the balance.
President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
© 2026 KFF